Amgen Inc. vs Gilead Sciences, Inc. — Stock Comparison
Q·Score Breakdown
7.2
Buy
Overall
8.1
Buy
Quality
Health
Growth
Valuation
Sentiment
AMGN
High-quality business with 106% return on equity and 21% profit margins.
⚠ high leverage at 6.4× debt-to-equity.
GILD
High-quality business with 41% return on equity and 29% profit margins.
Analyst Consensus
HOLD
Target $352.73 (+1.7%)
30 analysts
BUY
Target $158.36 (+20.4%)
28 analysts
Fundamentals
AMGN
GILD
24.4×
Trailing P/E
19.4×
14.8×
Forward P/E
13.7×
21.0%
Profit Margin
28.9%
70.8%
Gross Margin
78.8%
106.1%
ROE
40.7%
8.6%
Revenue Growth
4.7%
112.1%
Earnings Growth
23.4%
0.47
Beta
0.40
—
Price / Book
—
$186.9B
Market Cap
$163.2B
$261 – $391
52-Week Range
$95 – $157
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.